Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Drug concentration Live cell count Average live cell count, DMSO control Average live cell count (time = 0) Log10(drug concentration) GR value Relative cell count (treatment versus DMSO) Cell doublings (DMSO control) Experiment name
Hs 578T Torin1 3 72
0.001
4036.8 4147.8 571.3
-3.0
0.981 0.973 2.860
Hs578T Torin1 3
Hs 578T Torin2 3 72
0.001
3608.8 4103.3 571.3
-3.0
0.912 0.879 2.844
Hs578T Torin2 3
Hs 578T Trametinib 3 72
0.001
3280.0 4062.0 571.3
-3.0
0.854 0.807 2.830
Hs578T Trametinib 3
Hs 578T WYE-125132 3 72
0.001
3852.0 4195.3 571.3
-3.0
0.942 0.918 2.876
Hs578T WYE125132 3
Hs 578T XL147 3 72
0.001
4128.5 4203.0 571.3
-3.0
0.988 0.982 2.879
Hs578T XL147 3
Hs 578T ZSTK474 3 72
0.001
4138.3 4157.8 571.3
-3.0
0.997 0.995 2.863
Hs578T ZSTK474 3